Mr. Shantha Bandara
Sunshine Healthcare Lanka (SHL), the healthcare arm of the diversified Sri Lankan conglomerate Sunshine Holdings has appointed Shantha Bandara as the Chief Executive Officer of its pharmaceutical division. The appointment came into effect from July 01, 2020.
Mr. Bandara, who was the Chief Operating Officer of Sunshine Pharmaceuticals, counts more than 23 years of experience in the pharmaceutical industry. He joined Sunshine Healthcare in 2011 and rose through the ranks to become the COO in 2018, where he has been spearheading the pharmaceutical business to reach newer heights and become one of the leading healthcare companies in Sri Lanka since then. He has been instrumental in growing the healthcare business to be the key driver of the group’s financial performance, helping Sunshine Holdings to sustain its growth over the last two years amidst tough macroeconomic conditions, the company said in a media release.
The Committee on High Posts has approved the nomination of Former Air Force Commander Air Chief Marshal (Retd.)
Former Chairman of SriLankan Airlines, Nishantha Wickramasinghe, arrested on allegation of corruption by the Commission to Investigate Allegations of Bribery or Corruption (CIABOC) has been remanded until July 1 by the Colombo Magistrate court.
Leave Comments